Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | IONS | Common Stock | 23.1K | Dec 31, 2022 | Direct | ||||||
holding | IONS | Common Stock | 2K | Dec 31, 2022 | By Wife | F1 |
Id | Content |
---|---|
F1 | These securities are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. Genworks 2 owned such shares of common stock on September 20, 2018, the date on which the reporting person became a director of Ionis Pharmaceuticals, Inc. |